Literature DB >> 25292401

Peritoneal resting with heparinized lavage reverses peritoneal type I membrane failure. A comparative study of the resting effects on normal membranes.

Erika De Sousa1, Gloria Del Peso1, Laura Alvarez1, Silvia Ros1, Ana Mateus1, Ana Aguilar1, Rafael Selgas1, María-Auxiliadora Bajo1.   

Abstract

BACKGROUND: Ultrafiltration failure (UFF) is a serious complication of long-term peritoneal dialysis (PD). Peritoneal rest (PR) has been demonstrated as a valid treatment to reverse the functional changes that occur in UFF. The effects of PR on a normally functioning human peritoneum are unknown but are expected to be neutral. Our hypothesis was that PR positively modifies peritoneal function in patients with UFF, in contrast to the absence of effects when PR is applied under normal conditions. PATIENTS AND METHODS: We studied 84 PR periods, comparing 35 patients with UFF and 49 controls (resting for abdominal surgery with temporary discontinuation of PD). We analyzed peritoneal transport pre-PR and post-PR by calculating the mass transfer coefficients of creatinine (Cr-MTAC), the dialysate/plasma creatinine ratio (D/P Cr) and the ultrafiltration (UF).
RESULTS: Baseline data was similar for the 2 groups, although the UFF group had a longer median time in PD (39 [18 - 60] vs 10 [5 - 23] months; p = 0.00001). Peritoneal rest induced a decrease in D/P Cr, Cr-MTAC and an increase in UF capacity in the UFF group (p = 0.0001, p = 0.004 and p = 0.001, respectively), without causing changes in the control group. Peritoneal rest in patients with more than 6 months of UFF was not able to reduce peritoneal solute transport or improve UF capacity. Response to PR did not differ among UFF patients with or without a previous history of peritonitis. Peritoneal rest enabled patients with UFF to continue on PD for a median time of 23 months (range, 13 - 46 months).
CONCLUSIONS: Peritoneal rest induces functional changes in patients with UFF but not in those with no functional abnormalities. This demonstrates that PR works only when abnormal but reversible functional conditions are present. However, the effect is highly dependent on how early PR is applied.
Copyright © 2014 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Peritoneal transport; heparin; peritoneal dialysis; peritoneal rest; ultrafiltration failure

Mesh:

Substances:

Year:  2014        PMID: 25292401      PMCID: PMC4269495          DOI: 10.3747/pdi.2013.00286

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  22 in total

1.  Managing ultrafiltration failure by peritoneal resting.

Authors:  R Selgas; M A Bajo; M J Castro; J A Sánchez-Tomero; A Cirugeda
Journal:  Perit Dial Int       Date:  2000 Nov-Dec       Impact factor: 1.756

Review 2.  Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.

Authors:  S Mujais; K Nolph; R Gokal; P Blake; J Burkart; G Coles; Y Kawaguchi; H Kawanishi; S Korbet; R Krediet; B Lindholm; D Oreopoulos; B Rippe; R Selgas
Journal:  Perit Dial Int       Date:  2000       Impact factor: 1.756

Review 3.  Peritoneal membrane failure in peritoneal dialysis patients.

Authors:  Raymond T Krediet; Ssadie Van Esch; Watske Smit; Wieneke M Michels; Machteld M Zweers; Marja M Ho-Dac-Pannekeet; Dirk G Struijk
Journal:  Blood Purif       Date:  2002       Impact factor: 2.614

4.  Peritoneal resting and heparinization as an effective treatment for ultrafiltration failure in patients on CAPD.

Authors:  B Miranda; R Selgas; O Celadilla; J Muñoz; L Sánchez Sicilia
Journal:  Contrib Nephrol       Date:  1991       Impact factor: 1.580

5.  Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure.

Authors:  K Honda; K Nitta; S Horita; W Yumura; H Nihei
Journal:  Nephron       Date:  1996       Impact factor: 2.847

6.  Effects of peritoneal rest on peritoneal transport and peritoneal membrane thickening in continuous ambulatory peritoneal dialysis rats.

Authors:  Y L Kim; S H Kim; J H Kim; S J Kim; C D Kim; D K Cho; Y J Kim; J B Moberly
Journal:  Perit Dial Int       Date:  1999       Impact factor: 1.756

7.  Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study.

Authors:  Edwina A Brown; Simon J Davies; Peter Rutherford; Frederique Meeus; Mercedes Borras; Werner Riegel; Jose C Divino Filho; Edward Vonesh; Monique van Bree
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

8.  TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.

Authors:  Yoko Yoshio; Masanobu Miyazaki; Katsushige Abe; Tomoya Nishino; Akira Furusu; Yohei Mizuta; Takashi Harada; Yoshiyuki Ozono; Takehiko Koji; Shigeru Kohno
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

Review 9.  Experimental encapsulating peritoneal sclerosis models: pathogenesis and treatment.

Authors:  Sun-Hee Park; Yong-Lim Kim; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2008-11       Impact factor: 1.756

10.  Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis.

Authors:  Watske Smit; Marja M Ho-Dac-Pannekeet; Raymond T Krediet
Journal:  NDT Plus       Date:  2008-10
View more
  3 in total

Review 1.  Should peritoneal resting be advised in ultrafiltration failure associated with a fast peritoneal solute transport status?

Authors:  Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014 Nov-Dec       Impact factor: 1.756

2.  A Patient on Peritoneal Dialysis with Refractory Volume Overload.

Authors:  Martin Wilkie
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-16       Impact factor: 8.237

3.  A New Method to Increase Ultrafiltration in Peritoneal Dialysis: Steady Concentration Peritoneal Dialysis.

Authors:  Vicente Pérez-Díaz; Alfonso Pérez-Escudero; Sandra Sanz-Ballesteros; Guadalupe Rodríguez-Portela; Susana Valenciano-Martínez; Sofía Palomo-Aparicio; Esther Hernández-García; Luisa Sánchez-García; Raquel Gordillo-Martín; Hortensia Marcos-Sánchez
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.